Loading company…
Pillar Biosciences develops next-generation sequencing diagnostic products for clinical laboratories, based in Natick, US.
Founded in 2014 and headquartered in Natick, US, Pillar Biosciences makes next-generation sequencing (NGS) products, including VersaTile, SLIMamp and PiVAT, for clinical diagnostics. Its primary users are medical laboratories and clinicians. The company raised USD 34.5 mn in Series D funding on May 27, 2025, with investors including Illumina, Inc. and Soleus Capital, at a valuation of USD 271.84 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in